 |
levosimendan |
|---|---|
| Trade Name | |
| Orphan Indication | Amyotrophic lateral sclerosis |
| USA Market Approval | USA |
| USA Designation Date | 2017-04-10 00:00:00 |
| Sponsor | Orion Corporation;Orionintie 1, 0FI-02200 ESPOO; |
| |
levosimendan |
|---|---|
| Trade Name | |
| Orphan Indication | Amyotrophic lateral sclerosis |
| USA Market Approval | USA |
| USA Designation Date | 2017-04-10 00:00:00 |
| Sponsor | Orion Corporation;Orionintie 1, 0FI-02200 ESPOO; |